Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-09-15 Sale |
2021-11-02 4:04 pm |
NRX Pharmaceuticals Inc. | NRXP | Besthof Robert Chief Comm. & Patient Officer |
40,000 | $11.76 | $470,400 | 307,200 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-03-08 Option Award |
2022-03-10 4:04 pm |
N/A 2032-03-08 |
NRX Pharmaceuticals Inc. | NRXP | Besthof Robert Interim CEO |
100,000 | $2.61 | 347,200 (Direct) |
View |
| 2021-08-16 Exercise |
2021-11-02 4:04 pm |
N/A N/A |
NRX Pharmaceuticals Inc. | NRXP | Besthof Robert Chief Comm. & Patient Officer |
63,710 | $0.2 | 307,200 (Direct) |
View |
| 2021-08-16 Option Award |
2021-11-02 4:04 pm |
N/A N/A |
NRX Pharmaceuticals Inc. | NRXP | Besthof Robert Chief Comm. & Patient Officer |
36,290 | $0 | 307,200 (Direct) |
View |
| 2021-08-16 Conversion |
2021-11-02 4:04 pm |
N/A 2026-03-01 |
NRX Pharmaceuticals Inc. | NRXP | Besthof Robert Chief Comm. & Patient Officer |
100,000 | $0.2 | 307,200 (Direct) |
View |
| 2021-05-24 Option Award |
2021-06-10 6:44 pm |
N/A 2026-03-01 |
NRX Pharmaceuticals Inc. | NRXP | Besthof Robert Chief Comm. & Patient Officer |
694,400 | $0 | 694,400 (Direct) |
View |